| scholarly article | Q13442814 |
| P2093 | author name string | S M Schuster | |
| D Chakrabarti | |||
| H L Elford | |||
| K P Holland | |||
| C G Annis | |||
| V Bracchi | |||
| P2860 | cites work | Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique | Q29616826 |
| Transgenic mouse model of pharmacologic induction of fetal hemoglobin: studies using a new ribonucleotide reductase inhibitor, Didox | Q33487833 | ||
| A phase I and pharmacokinetic study of didox administered by 36 hour infusion. The Cancer Research Campaign Phase I/II Clinical Trials Committee | Q35981425 | ||
| A phase 1 and pharmacokinetic study of didox: a ribonucleotide reductase inhibitor | Q36465960 | ||
| Cloning and characterization of subunit genes of ribonucleotide reductase, a cell-cycle-regulated enzyme, from Plasmodium falciparum | Q36739511 | ||
| Enzymology of cancer cells (first of two parts). | Q39617270 | ||
| Reduction of Ribonucleotides | Q39805408 | ||
| Inhibition of nucleoside diphosphate reductase by hydroxybenzohydroxamic acid derivatives | Q39851209 | ||
| New ribonucleotide reductase inhibitors with antineoplastic activity | Q41486931 | ||
| Synthesis of hydroxy- and amino-substituted benzohydroxamic acids: inhibition of ribonucleotide reductase and antitumor activity | Q41692144 | ||
| 2-Acetylpyridine thiosemicarbazones. 10. 2-Propionyl-, 2-butyryl-, and 2-(2-methylpropionyl)pyridine thiosemicarbazones as potential antimalarial agents | Q42248215 | ||
| Ribonucleotide reductase and cell proliferation. I. Variations of ribonucleotide reductase activity with tumor growth rate in a series of rat hepatomas. | Q43608910 | ||
| 2-Acetylpyridine thiosemicarbazones. 12. Derivatives of 3-acetylisoquinoline as potential antimalarial agents | Q47918106 | ||
| Ribonucleotide reductases | Q68930869 | ||
| Regulation of ribonucleotide reductase in mammalian cells by chemotherapeutic agents | Q72661476 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antimalarial | Q521616 |
| P1104 | number of pages | 3 | |
| P304 | page(s) | 2456-2458 | |
| P577 | publication date | 1998-09-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Antimalarial activities of polyhydroxyphenyl and hydroxamic acid derivatives | |
| P478 | volume | 42 |
| Q44693545 | A single aquaporin gene encodes a water/glycerol/urea facilitator in Toxoplasma gondii with similarity to plant tonoplast intrinsic proteins |
| Q43189699 | Activity of hydroxyurea against Leishmania mexicana. |
| Q46086152 | Bench scale production of benzohydroxamic acid using acyl transfer activity of amidase from Alcaligenes sp. MTCC 10674. |
| Q39110541 | Digalloylresveratrol, a novel resveratrol analog inhibits the growth of human pancreatic cancer cells. |
| Q30042887 | Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an active-site histidine |
| Q60328312 | Hydroxamic Acids − An Intriguing Family of Enzyme Inhibitors and Biomedical Ligands |
| Q79302492 | Hydroxamic acids: proton donor and acceptor strength for use in drug design |
| Q36816497 | Protein phosphorylation during Plasmodium berghei gametogenesis. |
| Q39453006 | Pyrimidine metabolism in schistosomes: A comparison with other parasites and the search for potential chemotherapeutic targets |
| Q36105776 | Recent advances in the search for newer antimalarial agents |
| Q37426436 | Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies |
| Q84230612 | Understanding the molecular interactions of different radical scavengers with ribonucleotide reductase M2 (hRRM2) domain: opening the gates and gaining access |
Search more.